Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Derek J Royer, Alex W Cohen & Daniel JJ Carr. (2015) The current state of vaccine development for ocular HSV-1 infection. Expert Review of Ophthalmology 10:2, pages 113-126.
Read now
Read now
Thorsten Demberg & Marjorie Robert-Guroff. (2009) Mucosal Immunity and Protection Against HIV/SIV Infection: Strategies and Challenges for Vaccine Design. International Reviews of Immunology 28:1-2, pages 20-48.
Read now
Read now
L Jean Patterson & Marjorie Robert-Guroff. (2008) Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development. Expert Opinion on Biological Therapy 8:9, pages 1347-1363.
Read now
Read now
Tanu Chawla, Navin Khanna & Sathyamangalam Swaminathan. (2008) Adenovirus-vectored vaccines. Expert Opinion on Therapeutic Patents 18:3, pages 293-307.
Read now
Read now
Articles from other publishers (26)
Qiang Liu, Yue Li, Zhenwu Luo, Guibo Yang, Yong Liu, Ying Liu, Maosheng Sun, Jiejie Dai, Qihan Li, Chuan Qin & Yiming Shao. (2015) HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection. AIDS 29:6, pages 649-658.
Crossref
Crossref
Claire-Anne Siegrist. 2013. Vaccines. Vaccines
14
32
.
Olga Borges & Gerrit Borchard. 2013. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines. Novel Immune Potentiators and Delivery Technologies for Next Generation Vaccines
65
80
.
Rong Zhu, Weijin Huang, Wenbo Wang, Qiang Liu, Jianhui Nie, Shufang Meng, Yongxin Yu & Youchun Wang. (2012) Comparison on Virulence and Immunogenicity of Two Recombinant Vaccinia Vaccines, Tian Tan and Guang9 Strains, Expressing the HIV-1 Envelope Gene. PLoS ONE 7:11, pages e48343.
Crossref
Crossref
Thomas Mourez, Mariana Mesel-Lemoine, Chantal Combredet, Val?rie Najburg, Nad?ge Cayet & Fr?d?ric Tangy. (2011) A chimeric measles virus with a lentiviral envelope replicates exclusively in CD4+/CCR5+ cells. Virology 419:2, pages 117-125.
Crossref
Crossref
Rachmat Hidajat, Seraphin Kuate, David Venzon, Vaniambadi Kalyanaraman, Irene Kalisz, James Treece, Ying Lian, Susan W. Barnett & Marjorie Robert-Guroff. (2010) Construction and immunogenicity of replication-competent adenovirus 5 host range mutant recombinants expressing HIV-1 gp160 of SF162 and TV1 strains. Vaccine 28:23, pages 3963-3971.
Crossref
Crossref
Olga Borges, Filipa Lebre, Dulce Bento, Gerrit Borchard & Hans E. Junginger. (2009) Mucosal Vaccines: Recent Progress in Understanding the Natural Barriers. Pharmaceutical Research 27:2, pages 211-223.
Crossref
Crossref
Ruth H. Florese, Thorsten Demberg, Peng Xiao, LaRene Kuller, Kay Larsen, L. Ebonita Summers, David Venzon, Aurelio Cafaro, Barbara Ensoli & Marjorie Robert-Guroff. (2009) Contribution of Nonneutralizing Vaccine-Elicited Antibody Activities to Improved Protective Efficacy in Rhesus Macaques Immunized with Tat/Env Compared with Multigenic Vaccines. The Journal of Immunology 182:6, pages 3718-3727.
Crossref
Crossref
Rachmat Hidajat, Peng Xiao, Qifeng Zhou, David Venzon, L. Ebonita Summers, Vaniambadi S. Kalyanaraman, David C. Montefiori & Marjorie Robert-Guroff. (2009)
Correlation of Vaccine-Elicited Systemic and Mucosal Nonneutralizing Antibody Activities with Reduced Acute Viremia following Intrarectal Simian Immunodeficiency Virus SIV
mac251
Challenge of Rhesus Macaques
. Journal of Virology 83:2, pages 791-801.
Crossref
Crossref
Aurelio Cafaro, Iole Macchia, Maria Teresa Maggiorella, Fausto Titti & Barbara Ensoli. 2009. Pharmaceutical Biotechnology. Pharmaceutical Biotechnology
189
242
.
Thorsten Demberg, Jean D. Boyer, Nina Malkevich, L. Jean Patterson, David Venzon, Ebonita L. Summers, Irene Kalisz, V. S. Kalyanaraman, Eun Mi Lee, David B. Weiner & Marjorie Robert-Guroff. (2008)
Sequential Priming with Simian Immunodeficiency Virus (SIV) DNA Vaccines, with or without Encoded Cytokines, and a Replicating Adenovirus-SIV Recombinant Followed by Protein Boosting Does Not Control a Pathogenic SIV
mac251
Mucosal Challenge
. Journal of Virology 82:21, pages 10911-10921.
Crossref
Crossref
Kaifan Dai, Ying Liu, Mingjie Liu, Jianqing Xu, Wei Huang, Xianggang Huang, Lianxing Liu, Yanmin Wan, Yanling Hao & Yiming Shao. (2008) Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes. Vaccine 26:39, pages 5062-5071.
Crossref
Crossref
Claire-Anne Siegrist. 2008. Vaccines. Vaccines
17
36
.
Xianggang Huang, Lianxing Liu, Li Ren, Chao Qiu, Yanmin Wan & Jianqing Xu. (2007) Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses. Vaccine 25:52, pages 8874-8884.
Crossref
Crossref
Marjorie Robert-Guroff. (2007) Replicating and non-replicating viral vectors for vaccine development. Current Opinion in Biotechnology 18:6, pages 546-556.
Crossref
Crossref
Yi-ming Shao. (2008) AIDS research and its role in China’s AIDS prevention and control policies. Virologica Sinica 22:6, pages 421-425.
Crossref
Crossref
Mattias N. E. Forsell, Gerald M. McInerney, Pia Dosenovic, Åsa S. Hidmark, Christopher Eriksson, Peter Liljeström, Christoph Grundner & Gunilla B. Karlsson Hedestam. (2007) Increased human immunodeficiency virus type 1 Env expression and antibody induction using an enhanced alphavirus vector. Journal of General Virology 88:10, pages 2774-2779.
Crossref
Crossref
Aleksandra Bozac, Elena Berto, Federica Vasquez, Paola Grandi, Antonella Caputo, Roberto Manservigi, Barbara Ensoli & Peggy Marconi. (2006) Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses. Vaccine 24:49-50, pages 7148-7158.
Crossref
Crossref
LASSE VINNER, DOMINIC THERRIEN, EDD WEE, INGA LAURSEN, TOMÀŠ HANKE, SYLVIE L. CORBET & ANDERS FOMSGAARD. (2006) Immune response in rhesus macaques after mixed modality immunisations with DNA, recombinant adenovirus and recombinant gp120 from human immunodeficiency virus type 1. APMIS 114:10, pages 690-699.
Crossref
Crossref
Joseph J. Mattapallil, Brenna Hill, Daniel C. Douek & Mario Roederer. (2006) Systemic vaccination prevents the total destruction of mucosal CD4 T cells during acute SIV challenge. Journal of Medical Primatology 35:4-5, pages 217-224.
Crossref
Crossref
Joseph J Mattapallil & Mario Roederer. (2006) HIV vaccines: can mucosal CD4 T cells be protected?. Current Opinion in HIV and AIDS 1:4, pages 272-276.
Crossref
Crossref
Marian R. Neutra & Pamela A. Kozlowski. (2006) Mucosal vaccines: the promise and the challenge. Nature Reviews Immunology 6:2, pages 148-158.
Crossref
Crossref
Stephen Dunham & Oswald Jarrett. 2006. In vivo Models of HIV Disease and Control. In vivo Models of HIV Disease and Control
293
332
.
Kendall A Smith. (2005) The continuing HIV vaccine saga: naked emperors alongside fairy godmothers. Medical Immunology 4:1.
Crossref
Crossref
B. Verrier. (2005) Therapeutic vaccination for chronic infectious diseases: Lessons from HIV-1. Journal of Clinical Virology 34, pages S9-S12.
Crossref
Crossref
Jun Zhao, Rebecca Voltan, Bo Peng, Alberta Davis-Warren, V.S. Kalyanaraman, W. Gregory Alvord, Kris Aldrich, Daniela Bernasconi, Stefano Buttò, Aurelio Cafaro, Barbara Ensoli & Marjorie Robert-Guroff. (2005) Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag. Virology 342:1, pages 1-12.
Crossref
Crossref